Thomas Jefferson University Hospital Onc Dept — Philadelphia, Pennsylvania

Thomas Jefferson University Hospital Onc Dept is a clinical research site located in Philadelphia, Pennsylvania, United States 19107-5098.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Thomas Jefferson University Hospital Onc Dept has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3, Squamous Lung Cancer With FGFR1 Amplification, Bladder Cancer With FGFR3 Mutation or Fusion.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University Hospital Onc Dept?

Thomas Jefferson University Hospital Onc Dept has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University Hospital Onc Dept conducted?

Thomas Jefferson University Hospital Onc Dept has 1 clinical trials on record. Their work covers Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3, Squamous Lung Cancer With FGFR1 Amplification, Bladder Cancer With FGFR3 Mutation or Fusion.

Is Thomas Jefferson University Hospital Onc Dept accredited by Crixeo Health?

Thomas Jefferson University Hospital Onc Dept has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thomas Jefferson University Hospital Onc Dept?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.